Related Experiment Videos
[Antithrombotic treatment in connection with PTCA. New substances and regimes are coming]
F Scherstén1, L Grip, H Emanuelsson
1Kardiologdivisionen, Sahlgrenska sjukhuset, Göteborg.
Lakartidningen
|June 26, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacodynamics, pharmacokinetics and safety of ticagrelor in Asian patients with stable coronary artery disease.
Cardiovascular intervention and therapeutics·2014
Substance P alterations in skin and brain of chronically stressed atopic-like mice.
Journal of the European Academy of Dermatology and Venereology : JEADV·2012
Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial.
International journal of clinical practice·2009
Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.
Journal of internal medicine·2007
[Rare manifestations of giant cell arteritis].
Lakartidningen·2026
[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].
Lakartidningen·2026
[Postoperative atrial fibrillation after open heart surgery].
Lakartidningen·2026
[Interaction between psychotic patients and AI-driven chatbots].
Lakartidningen·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026
Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.
Immunity, inflammation and disease·2026